Cargando…

Risk Factors for Mortality in Hospitalized Coronavirus Disease 2019 Patients

Detalles Bibliográficos
Autores principales:	Dietl, Beatriz, Martínez-Camblor, Pablo, Almagro, Pere
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711168/ https://www.ncbi.nlm.nih.gov/pubmed/33280753 http://dx.doi.org/10.1016/j.chest.2020.07.097

Ejemplares similares

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Letter to the editor regarding: “Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care”
por: Almagro, Pere, et al.
Publicado: (2017)

Left Ventricular Systolic Function and Inpatient Mortality in Patients Hospitalized with Coronavirus Disease 2019 (COVID-19)
por: Faridi, Kamil F., et al.
Publicado: (2020)

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019
por: Mombrun, Martin, et al.
Publicado: (2021)

Risk factors in blood for attacks of angina in patients with coronavirus disease 2019 and stable angina
por: Geng, Song, et al.
Publicado: (2023)

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
por: Zhang, Fengqin, et al.
Publicado: (2022)

A More Accurate Measurement of the Burden of Coronavirus Disease 2019 Hospitalizations
por: Vu, Christina, et al.
Publicado: (2022)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge
por: Renelus, Benjamin D., et al.
Publicado: (2020)

Efficacy and safety of hospital-based group medical quarantine for dialysis patients exposed to coronavirus disease 2019
por: Zuo, Li, et al.
Publicado: (2022)

Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Clinical characteristics of 1327 patients with coronavirus disease 2019 (COVID-19) in the largest Fangcang shelter hospital in Wuhan
por: Lu, Chong, et al.
Publicado: (2021)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Guo, Kaibo, et al.
Publicado: (2020)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Zhang, Guosen, et al.
Publicado: (2020)

Gut Microbiome Metabolism Drives the Resolution of Patients With Coronavirus Disease 2019
por: Zhang, Yu-Hang, et al.
Publicado: (2022)

Coronavirus disease 2019 presenting with conjunctivitis as the first symptom
por: Casalino, Giuseppe, et al.
Publicado: (2020)

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
por: Delgado-López, Pedro David, et al.
Publicado: (2021)

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019
por: Tana, Claudio, et al.
Publicado: (2021)

Zinc and Coronavirus Disease 2019: Causal or Casual Association?
por: Khurana, Alkesh Kumar, et al.
Publicado: (2021)

Exacerbation of livedoid vasculopathy after Coronavirus disease 2019
por: Kawabe, Ryoko, et al.
Publicado: (2022)

Effective strategies to prevent in-hospital infection in the emergency department during the novel coronavirus disease 2019 pandemic
por: Kung, Chia-Te, et al.
Publicado: (2021)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
por: Calleri, Alberto, et al.
Publicado: (2022)

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
por: Agarwal, Shivani, et al.
Publicado: (2020)

Risk factors for in-hospital mortality in patients with cancer and COVID-19 – Authors' reply
por: Yang, Kunyu, et al.
Publicado: (2020)

Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)
por: Salik, Irim, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
por: Georgiev, Tsvetoslav
Publicado: (2020)

Diabetic retinopathy screening during the coronavirus disease 2019 pandemic
por: Shih, Kendrick C., et al.
Publicado: (2020)

Airborne transmission of coronavirus disease 2019: a clinician’s perspective
por: Oh, Myoung-don
Publicado: (2021)

The many faces of coronavirus disease 2019: COVID-19 and the liver
por: Almas, Talal, et al.
Publicado: (2021)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019
por: Dessemon, Juliette, et al.
Publicado: (2022)

Digital Mentorship in Cardiothoracic Surgery in the Coronavirus Disease 2019 Era
por: Xu, Samantha, et al.
Publicado: (2022)

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019
por: Tao, Kun-ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2n99kbnm5phru6muacuab1cn63